Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure

Neuroscience. 2013 Oct 10:250:599-613. doi: 10.1016/j.neuroscience.2013.07.054. Epub 2013 Jul 30.

Abstract

Experiments were done to investigate whether hypothalamic hypocretin-1 (hcrt-1; orexin-A) neurons that sent axonal projections to cardiovascular responsive sites in the nucleus of the solitary tract (NTS) co-expressed leucine-enkephalin (L-Enk), and to determine the effects of co-administration of hcrt-1 and D-Ala2,D-Leu5-Enkephalin (DADL) into NTS on mean arterial pressure (MAP) and heart rate. In the first series, in the Wistar rat the retrograde tract-tracer fluorogold (FG) was microinjected (50nl) into caudal NTS sites at which L-glutamate (0.25 M; 10 nl) elicited decreases in MAP and where fibers hcrt-1 immunoreactive fibers were observed that also contained L-Enk immunoreactivity. Of the number of hypothalamic hcrt-1 immunoreactive neurons identified ipsilateral to the NTS injection site (1207 ± 78), 32.3 ± 2.3% co-expressed L-Enk immunoreactivity and of these, 2.6 ± 1.1% were retrogradely labeled with FG. Hcrt-1/L-Enk neurons projecting to NTS were found mainly within the perifornical region. In the second series, the region of caudal NTS found to contain axons that co-expressed hcrt-1 and L-Enk immunoreactivity was microinjected with a combination of hcrt-1 and DADL in α-chloralose anesthetized Wistar rats. Microinjection of DADL into NTS elicited depressor and bradycardia responses similar to those elicited by microinjection of hcrt-1. An hcrt-1 injection immediately after the DADL injection elicited an almost twofold increase in the magnitude of the depressor and bradycardia responses compared to those elicited by hcrt-1 alone. Prior injections of the non-specific opioid receptor antagonist naloxone or the specific opioid δ-receptor antagonist ICI 154,129 significantly attenuated the cardiovascular responses to the combined hcrt-1-DADL injections. Taken together, these data suggest that activation of hypothalamic-opioidergic neuronal systems contribute to the NTS hcrt-1 induced cardiovascular responses, and that this descending hypothalamo-medullary pathway may represent the anatomical substrate by which hcrt-1/L-Enk neurons function in the coordination of autonomic-cardiovascular responses during different behavioral states.

Keywords: 3rd ventricle; 4V; 4th ventricle; AP; Ap; Com; D-Ala2,D-Leu5-Enkephalin; DADL; DMH; DMV; DOR; FG; Fluorogold; HR; ICI 154,129; L-Enk; LHA; MAP; MOR; NTS; PBS; PVp; PeF; STN; Sc; Sg; Slt; Sm; Svl; V3; VMH; XII; ZI; area postrema; arterial pressure; blood pressure regulation; cc; central canal; central opioid systems; central subnucleus of nucleus of the solitary tract; commissural subnucleus of nucleus of the solitary tract; dorsal motor nucleus of the vagus; dorsomedial hypothalamic nucleus; fasiculus gracilis; fornix; fx; gelantinus subnucleus of nucleus of the solitary tract; gr; hcrt; hcrt-1; hcrt-2; heart rate; hypocretin (orexin); hypocretin-1 (orexin-A); hypocretin-2 (orexin-B); hypoglossal nucleus; ic; internal capsule; lateral hypothalamic area; lateral subnucleus of nucleus of the solitary tract; leucine-enkephalin; mammilothalamic tract; mean arterial pressure; medial subnucleus of nucleus of the solitary tract; mt; nal; naloxone; nucleus of the solitary tract; orexin; perifornical hypothalamic area; periventricular hypothalamic area; phosphate-buffered saline; subthalamic nucleus; ventrolateral subnucleus of nucleus of the solitary tract; ventromedial hypothalamic nucleus; zona incerta; δ- and μ-opioid receptors; δ-opioid receptor; δ-opioid receptor antagonist N-diallyl-Tyr-GIy-Gly-(CH2S)Phe-Leu; μ-opioid receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arterial Pressure / drug effects
  • Arterial Pressure / physiology*
  • Data Interpretation, Statistical
  • Enkephalin, Leucine / analogs & derivatives
  • Enkephalin, Leucine / metabolism*
  • Enkephalin, Leucine / pharmacology
  • Enkephalin, Leucine-2-Alanine / analogs & derivatives
  • Enkephalin, Leucine-2-Alanine / pharmacology
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Hypothalamus / cytology
  • Hypothalamus / metabolism
  • Hypothalamus / physiology*
  • Immunohistochemistry
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Intracellular Signaling Peptides and Proteins / pharmacology
  • Male
  • Melphalan / analogs & derivatives
  • Melphalan / pharmacology
  • Microinjections
  • Narcotic Antagonists / pharmacology
  • Neural Pathways / cytology
  • Neural Pathways / metabolism
  • Neural Pathways / physiology*
  • Neurons / metabolism
  • Neurons / physiology*
  • Neuropeptides / metabolism*
  • Neuropeptides / pharmacology
  • Orexins
  • Rats
  • Rats, Wistar
  • Solitary Nucleus / cytology
  • Solitary Nucleus / metabolism
  • Solitary Nucleus / physiology*
  • Stilbamidines

Substances

  • 2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt
  • Intracellular Signaling Peptides and Proteins
  • Narcotic Antagonists
  • Neuropeptides
  • Orexins
  • Stilbamidines
  • Enkephalin, Leucine
  • Enkephalin, Leucine-2-Alanine
  • enkephalin-Leu, Ala(2)-melphalan methyl ester-
  • ICI 154129
  • Melphalan